U.S. flag

An official website of the United States government

NM_000322.5(PRPH2):c.421T>C (p.Tyr141His) AND PRPH2-related disorder

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 13, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002513911.3

Allele description [Variation Report for NM_000322.5(PRPH2):c.421T>C (p.Tyr141His)]

NM_000322.5(PRPH2):c.421T>C (p.Tyr141His)

Gene:
PRPH2:peripherin 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
6p21.1
Genomic location:
Preferred name:
NM_000322.5(PRPH2):c.421T>C (p.Tyr141His)
HGVS:
  • NC_000006.12:g.42721914A>G
  • NG_009176.2:g.5707T>C
  • NM_000322.5:c.421T>CMANE SELECT
  • NP_000313.2:p.Tyr141His
  • NC_000006.11:g.42689652A>G
  • NG_009176.1:g.5707T>C
  • NM_000322.4:c.421T>C
Protein change:
Y141H
Links:
dbSNP: rs61755780
NCBI 1000 Genomes Browser:
rs61755780
Molecular consequence:
  • NM_000322.5:c.421T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
PRPH2-related disorder
Synonyms:
PRPH2-Related Disorders; PRPH2-related condition
Identifiers:
MedGen: CN239395

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003439414Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Nov 13, 2023)
germlineclinical testing

PubMed (9)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Two novel mutations (Y141H; C214Y) and previously published mutation (R142W) in the RDS-peripherin gene in autosomal dominant macular dystrophies in Spanish families.

Trujillo MJ, Martinez-Gimeno M, Giménez A, Lorda I, Bueno J, García-Sandoval B, Ramos C, Carballo M, Ayuso C.

Hum Mutat. 2001;17(1):80. No abstract available.

PubMed [citation]
PMID:
11139263

High prevalence of mutations in peripherin/RDS in autosomal dominant macular dystrophies in a Spanish population.

Gamundi MJ, Hernan I, Muntanyola M, Trujillo MJ, García-Sandoval B, Ayuso C, Baiget M, Carballo M.

Mol Vis. 2007 Jun 28;13:1031-7.

PubMed [citation]
PMID:
17653047
PMCID:
PMC2776544
See all PubMed Citations (9)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003439414.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (9)

Description

This sequence change replaces tyrosine, which is neutral and polar, with histidine, which is basic and polar, at codon 141 of the PRPH2 protein (p.Tyr141His). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with clinical features of PRPH2-related conditions (PMID: 11139263, 17653047, 34327195; Invitae). ClinVar contains an entry for this variant (Variation ID: 98665). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PRPH2 protein function with a positive predictive value of 95%. This variant disrupts the p.Tyr141 amino acid residue in PRPH2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 16113362, 16799052, 25001182, 25082885, 25097241). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 26, 2024